OMIC

Companies
NASDAQ
Singular Genomics Systems, Inc.
Health Care
Price Chart
Overview

About OMIC

Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.

Market Cap
$23.7M
Volume
Avg. Volume
P/E Ratio
Dividend Yield
0.00%
Employees
188.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Medical Instruments & Supplies
Risk & Correlation Analysis
Market Correlation
1.17
Moderate Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
High Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for OMIC.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, OMIC shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$23.7M
Volume
P/E Ratio
Dividend Yield0.00%

PortfolioPilot Analysis

Get AI-powered insights on how OMIC fits into your investment strategy and portfolio diversification.

Pricing info last updated June 26, 2025 (after market close)Other info last updated April 2, 2025